SEC Form 6-K filed by Exscientia Plc

​

​

​	Exhibit Number	​	​	Description of Exhibit	​
​	99.1	​	​	Definitive Joint Proxy Statement of Exscientia plc and Recursion Pharmaceuticals, Inc., dated October 10, 2024, in connection with the shareholder meetings of Exscientia plc and the special meeting of stockholders of Recursion Pharmaceuticals, Inc., each related to the transactions contemplated by the Transaction Agreement by and between Exscientia plc and Recursion Pharmaceuticals, Inc. dated as of August 8, 2024	​

​

​	​	​	​	EXSCIENTIA PLC				​
​	​	​	​	By:	​	​	/s/ Ben Taylor ​ Name: Ben Taylor Title:  Chief Financial Officer	​
​	Date:	​	​	​	​	​	​	​
​	October 10, 2024	​	​	​	​	​	​	​